← All trials

NCT04938817

Phase 1/Phase 2Interventional

Trials that are a combination of phases 1 and 2.

View on ClinicalTrials.gov ↗

Timeline

Start date
Aug 19, 2021
Primary completion
Nov 2, 2026
Completion date
Nov 2, 2026
First posted
Jun 24, 2021
Last posted
Nov 29, 2021
Enrollment
80
Arms / groups
4 / —
Source
AACT · ingestion pipeline

Sponsors

Drugs studied

Indications studied

CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.